191 related articles for article (PubMed ID: 14578100)
1. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
3. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
[TBL] [Abstract][Full Text] [Related]
5. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
Padley DJ; Dietz AB; Gastineau DA
Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
[TBL] [Abstract][Full Text] [Related]
6. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
Cheah PL; Ong CW; Crispin P
Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
[TBL] [Abstract][Full Text] [Related]
7. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
[TBL] [Abstract][Full Text] [Related]
8. Autologous transplant: microbial contamination of hematopoietic stem cell products.
Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
[TBL] [Abstract][Full Text] [Related]
9. Technology evaluation: Stem-cell therapy, Aastrom Biosciences Inc.
Morse MA
Curr Opin Mol Ther; 1999 Dec; 1(6):745-52. PubMed ID: 19629872
[TBL] [Abstract][Full Text] [Related]
10. Microbial contamination of harvested bone marrow and peripheral blood.
Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
[TBL] [Abstract][Full Text] [Related]
11. Microbial contamination of peripheral blood stem cell collections.
Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
[TBL] [Abstract][Full Text] [Related]
12. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
[TBL] [Abstract][Full Text] [Related]
13. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
[TBL] [Abstract][Full Text] [Related]
14. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
Kelly M; Roy DC; Labbe AC; Laverdiere M
Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
[TBL] [Abstract][Full Text] [Related]
15. Safety control of peripheral blood progenitor cell processing-eight year-survey of microbiological contamination and bag ruptures in a single institution.
Mele L; Dallavalle FM; Verri MG; Balza G; Allione B; Salvi F; Levis A; Caraccio V; Borzini P
Transfus Apher Sci; 2005 Nov; 33(3):269-74. PubMed ID: 16239124
[TBL] [Abstract][Full Text] [Related]
16. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
[TBL] [Abstract][Full Text] [Related]
17. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
18. Ex-vivo purging of hematopoietic progenitor cells.
de Lima M; Shpall EJ
Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
[TBL] [Abstract][Full Text] [Related]
19. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.
Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R
Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209
[TBL] [Abstract][Full Text] [Related]
20. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method.
Khuu HM; Patel N; Carter CS; Murray PR; Read EJ
Transfusion; 2006 Dec; 46(12):2071-82. PubMed ID: 17176318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]